Spots Global Cancer Trial Database for Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)
Official Title: A Randomized, Double Blind, Parallel, Three Arm Trial Evaluating the Efficacy and Safety of Ipilimumab (BMS-734016) in Combination With Paclitaxel/Carboplatin Compared to Paclitaxel/Carboplatin Alone in Previously Untreated Subjects With Lung Cancer
Study ID: NCT00527735
Study Description
Brief Summary: The purpose of the study is to determine whether ipilimumab given with paclitaxel/carboplatin has clinical benefit when compared with paclitaxel/carboplatin alone in patients with previously untreated lung cancer.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Birmingham Hematology & Oncology Assoc. Llc, Birmingham, Alabama, United States
Mayo Clinic, Scottsdale, Arizona, United States
Acrc/Arizona Clinical Research Center, Inc., Tucson, Arizona, United States
Compassionate Cancer Care Medical Group, Corona, California, United States
Compassionate Cancer Care Medical Group, Inc., Fountain Valley, California, United States
The Angeles Clinic & Research Institute, Inc, Los Angeles, California, United States
Oncology Care Medical Associates, Montebello, California, United States
Compassionate Cancer Care Medical Group, Riverside, California, United States
Sharp Clinical Oncology Research, San Diego, California, United States
M D Anderson Cancer Center- Orlando, Orlando, Florida, United States
Georgia Cancer Specialists, Atlanta, Georgia, United States
University Of Chicago Medical Center, Chicago, Illinois, United States
Local Institution, Park Ridge, Illinois, United States
Kentucky Cancer Clinic, Hazard, Kentucky, United States
The John R. Marsh Cancer Center, Hagerstown, Maryland, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
The Cancer Center, Minneapolis, Minnesota, United States
Nevada Cancer Institute, Las Vegas, Nevada, United States
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
Local Institution, New York, New York, United States
Cmc-Northeast/ Northeast Oncology Associates, Concord, North Carolina, United States
Gabrail Cancer Center, Canton, Ohio, United States
Hematology Oncology Consultants, Inc, Columbus, Ohio, United States
St. Mary Medical Center, Langhorne, Pennsylvania, United States
Guthrie Clinical Research, Sayre, Pennsylvania, United States
Santee Hematology/Oncology, Sumter, South Carolina, United States
Southwest Cancer Treatment And Research Center, Lubbock, Texas, United States
Local Institution, Belfort, , France
Local Institution, Caen, , France
Local Institution, Marseille Cedex 9, , France
Local Institution, Rennes Cedex 9, , France
Local Institution, Bochum, , Germany
Local Institution, Coswig, , Germany
Local Institution, Ebensfeld, , Germany
Local Institution, Grosshansdorf, , Germany
Local Institution, Halle (Saale), , Germany
Local Institution, Hamburg, , Germany
Local Institution, Koeln, , Germany
Local Institution, Leipzig, , Germany
Local Institution, Mainz, , Germany
Local Institution, Muenchen, , Germany
Local Institution, Hyderabad, Andhra Pradesh, India
Local Institution, Navrangpura, Ahmedabad, Gujarat, India
Local Institution, Manipal, Karnataka, India
Local Institution, Trivandrum, Kerala, India
Local Institution, Vellore, , India
Local Institution, Genova, , Italy
Local Institution, Siena, , Italy
Local Institution, Torino, , Italy
Local Institution, Gdansk, , Poland
Local Institution, Krakow, , Poland
Local Institution, Olsztyn, , Poland
Local Institution, Szczecin, , Poland
Local Institution, Arkhangelsk, , Russian Federation
Local Institution, Chelyabinsk, , Russian Federation
Local Institution, Ivanovo, , Russian Federation
Local Institution, Moscow, , Russian Federation
Local Institution, Moscow, , Russian Federation
Local Institution, Moscow, , Russian Federation
Local Institution, Pyatigorsk, , Russian Federation
Local Institution, Saint-Petersburg, , Russian Federation
Local Institution, Sochi, , Russian Federation
Local Institution, St. Petersburg, , Russian Federation
Local Institution, St. Petersburg, , Russian Federation
Local Institution, St. Petersburg, , Russian Federation
Local Institution, St. Petersburg, , Russian Federation
Local Institution, Dnipropetrovsk, , Ukraine
Local Institution, Donetsk, , Ukraine
Local Institution, Kharkov, , Ukraine
Local Institution, Lviv, , Ukraine
Local Institution, Ternopol, , Ukraine
Local Institution, Uzhgorod, , Ukraine
Contact Details
Name: Bristol-Myers Squibb
Affiliation: Bristol-Myers Squibb
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
